Research map: Incidence and Predictors of Extracranial Bleeding on Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A COMBINE-AF Analysis

Back to the article

Papers in this map

  1. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study · Salim Yusuf · 2004 · 12112 citations · Cited by this paper
  2. Association of Pulmonary Vascular Remodeling With Cardiac Structure and Function, Pulmonary Pressure, and Heart Failure in Late Life: The Atherosclerosis Risk in Communities (ARIC) Study · 2026 · Related
  3. Edoxaban versus Warfarin in Patients with Atrial Fibrillation · Robert Patrick Giugliano · 2013 · 5198 citations · Cited by this paper
  4. AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026) · 2026 · Related
  5. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials · Christian Thomas Ruff · 2013 · 5074 citations · Cited by this paper
  6. Lipid Profile Testing and Interpretation · 2026 · Related
  7. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients · Sam Schulman · 2005 · 5069 citations · Cited by this paper
  8. Rapid Ultraoxygenated Recovery Without Preimplant Reanimation Using Older Donation After Circulatory Death Heart Donors · 2026 · Related
  9. Oral Apixaban for the Treatment of Acute Venous Thromboembolism · Giancarlo Agnelli · 2013 · 2335 citations · Cited by this paper
  10. Facilitation of Autophagosome-Lysosome Fusion by LAPTM4A: A Novel Strategy for Attenuating Myocardial Ischemia-Reperfusion Injury · 2026 · Related
  11. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study · Martin James O'Donnell · 2016 · 2315 citations · Cited by this paper
  12. Heart Failure Occurring in the Perinatal Period: A Scientific Statement From the American Heart Association · 2026 · Related
  13. How can I deal with missing data in my study? · Derrick Bennett · 2001 · 1623 citations · Cited by this paper
  14. Advancing Quality in the Evaluation, Surveillance, and Management of Aortic Stenosis: A Report From the AHA Target: AS Registry · 2026 · Related
  15. Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients: communication from the SSC of the ISTH · Scott S. Kaatz · 2015 · 1424 citations · Cited by this paper
  16. An Integrated Ecosystem for Cardiovascular Science and Health · 2026 · Related
  17. Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation · Renato D. Lópes · 2019 · 1225 citations · Cited by this paper
  18. Paclitaxel-Coated Balloon Versus Uncoated Balloon for Coronary In-Stent Restenosis: Two-Year Follow-Up of the AGENT-IDE Randomized Clinical Trial · 2026 · Related
  19. Sample size slippages in randomised trials: exclusions and the lost and wayward · Kenneth F. Schulz · 2002 · 654 citations · Cited by this paper
  20. A Multitask Deep Learning Model for Pediatric Echocardiography Analysis · 2026 · Related
  21. Anticoagulant Reversal, Blood Pressure Levels, and Anticoagulant Resumption in Patients With Anticoagulation-Related Intracerebral Hemorrhage · Joji B. Kuramatsu · 2015 · 568 citations · Cited by this paper
  22. The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study · Ziad Hijazi · 2016 · 490 citations · Cited by this paper
  23. Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry · Jan Beyer‐Westendorf · 2014 · 408 citations · Cited by this paper
  24. US Emergency Department Visits Attributed to Medication Harms, 2017-2019 · Daniel S. Budnitz · 2021 · 187 citations · Cited by this paper
  25. Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial · Claes Held · 2014 · 174 citations · Cited by this paper
  26. Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism · Isabelle Mahé · 2025 · 154 citations · Cited by this paper
  27. Clinical outcomes in patients with atrial fibrillation and frailty: insights from the ENGAGE AF-TIMI 48 trial · Chris Wilkinson · 2020 · 118 citations · Cited by this paper
  28. Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants · Rahul Aggarwal · 2023 · 113 citations · Cited by this paper
  29. Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation · Christian Thomas Ruff · 2025 · 112 citations · Cited by this paper
  30. Cross-Sectional Association of Frailty and Arterial Stiffness in Community-Dwelling Older Adults: The Framingham Heart Study · Ariela R. Orkaby · 2018 · 89 citations · Cited by this paper
  31. Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation · Maria Cecilia Bahit · 2016 · 80 citations · Cited by this paper
  32. Bleeding and New Cancer Diagnosis in Patients With Atherosclerosis · John W. Eikelboom · 2019 · 47 citations · Cited by this paper
  33. Aging and Vascular Disease: A Multidisciplinary Overview · Jeanette A.M. Maier · 2023 · 43 citations · Cited by this paper
  34. Estimating and displaying population attributable fractions using the R package: graphPAF · John P. Ferguson · 2024 · 42 citations · Cited by this paper
  35. What Is Missing From My Missing Data Plan? · Sharon D. Yeatts · 2015 · 41 citations · Cited by this paper
  36. Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation · Agneta G Siegbahn · 2021 · 40 citations · Cited by this paper
  37. Emergency Visits for Oral Anticoagulant Bleeding · Andrew Isaac Geller · 2019 · 38 citations · Cited by this paper
  38. Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale · Anthony Carnicelli · 2020 · 37 citations · Cited by this paper
  39. Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF‐TIMI 48 Trial · Kaijun Wang · 2017 · 32 citations · Cited by this paper

Source: OpenAlex (CC0)